Cargando…

Extending INR testing intervals in warfarin patients at a multi-center anticoagulation clinic

Warfarin has been used as an anticoagulant by millions of patients due to its effectiveness, availability, and low cost. Evidence on the safe extension of international normalized ratio (INR) testing frequency remains an area of interest, especially during the recent COVID-19 pandemic. The purpose o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papala, Michelle, Gillard, Deborah, Hardman, Jennifer, Romano, Teresa, Rein, Lisa E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497144/ https://www.ncbi.nlm.nih.gov/pubmed/34622376 http://dx.doi.org/10.1007/s11239-021-02566-5

Ejemplares similares

Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
por: Arbring, Kerstin, et al.
Publicado: (2013)

The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study
por: Gemmati, Donato, et al.
Publicado: (2016)

Warfarin/herbal drink interaction: Elevated INR: case report
Publicado: (2021)

A CONTROVERSY: WARFARIN FAILURE IN COVID-19 WITH SUPRATHERAPEUTIC INR
por: Ur Rahman, Saad
Publicado: (2023)

TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT)
por: Smith, Danielle E, et al.
Publicado: (2010)

Comparison of the effects of different treatment protocols on mortality in patients presenting with an INR≥10 due to warfarin-associated over-anticoagulation
por: İslam, Mehmet Muzaffer, et al.
Publicado: (2023)

Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?
por: Kim, Esther, et al.
Publicado: (2016)

Predictors for INR-control in a well-managed warfarin treatment setting
por: Björck, Fredrik, et al.
Publicado: (2018)

INR Goal Attainment and Oral Anticoagulation Knowledge of Patients Enrolled in an Anticoagulation Clinic in a Veterans Affairs Medical Center
por: Ryals, Casey A., et al.
Publicado: (2011)

Optimal INR level for warfarin therapy after mechanical mitral valve replacement
por: Kamthornthanakarn, Itthidet, et al.
Publicado: (2019)

Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management
por: Eljilany, Islam, et al.
Publicado: (2021)

Pillbox Use and INR Stability in a Prospective Cohort of New Warfarin Users
por: Dumas, Stephanie, et al.
Publicado: (2016)

Relationship between the Occurrence of Thromboembolism and INR Measurement Interval in Low Intensity Anticoagulation after Aortic Mechanical Valve Replacement
por: Rhie, Sangho, et al.
Publicado: (2011)

Enoxaparin-sodium/heparin/warfarin: Heparin-induced thrombocytopenia and elevated INR: case report
Publicado: (2021)

Determining INR Awareness of the Patients who Use Warfarin and Rates of Achieving the Target Dosage
por: Demir, Nazan, et al.
Publicado: (2020)

Does prophylactic antibiotic administration for tooth extraction affect PT-INR in patients taking warfarin?
por: Iwata, Eiji, et al.
Publicado: (2020)

Validation of an algorithm to predict decline in INR following warfarin cessation in patients undergoing invasive procedures
por: Kampouraki, Emmanouela, et al.
Publicado: (2019)

Warfarin Time in Therapeutic INR Range and Direct Oral Anticoagulant Adherence for Venous Thromboembolism Across the Spectrum of Weight and Body Mass Index: Findings from Veterans Health Administration
por: Din, Natasha, et al.
Publicado: (2023)

Differences in the INR evaluation of two different thromboplastins in patients with positivity to lupus anticoagulant in ongoing oral anticoagulation
por: Ferrazzi, Paola, et al.
Publicado: (2010)

Dynamic ‘Spot Sign’ Resolution following INR Correction in a Patient with Warfarin-Associated Intracerebral Hemorrhage
por: Chakraborty, S., et al.
Publicado: (2011)

Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation
por: Nelson, Winnie W., et al.
Publicado: (2014)

A case of successful concomitant administration of warfarin and uracil‐tegafur/leucovorin achieved by self‐measurement of INR
por: Watanabe, Norio, et al.
Publicado: (2017)

Effects of changing the timing of warfarin administration in combination with fluconazole on prolongation of the PT-INR: a case report
por: Akamatsu, Hayato, et al.
Publicado: (2023)

Effects of oral anticoagulation with various INR levels in deep vein thrombosis cases
por: Yetkin, Ufuk, et al.
Publicado: (2004)

Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
por: Haug, Kari Bente Foss, et al.
Publicado: (2008)

How Well Does the Target INR Level Maintain in Warfarin-Treated Patients with Non-ValvularAtrial Fibrillation?
por: Kim, Jun Hyung, et al.
Publicado: (2009)

Effects of structured patient education on knowledge level and INR control of patients receiving warfarin: Randomized Controlled Trial
por: Baysal, Ebru, et al.
Publicado: (2018)

Optimal INR level in patients with atrial fibrillation with EHRA type 2 valvular heart disease receiving warfarin
por: Luengsupabul, Sirote, et al.
Publicado: (2020)

New Oral Anticoagulants versus Warfarin for Cerebral Venous Thrombosis: A Multi-Center, Observational Study
por: Wasay, Mohammad, et al.
Publicado: (2019)

Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2023)

Analysis of Factors That Interrupt With INR Control in the First Anticoagulation Clinic Monitoring Jordanian Patients
por: Al-Momany, Nairooz H., et al.
Publicado: (2019)

Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants
por: Zhang, Xi, et al.
Publicado: (2023)

Assessment of the quality of anticoagulation management with warfarin in a tertiary care center
por: Albabtain, Monirah A., et al.
Publicado: (2020)

Is intravenous thrombolysis safe for acute ischemic stroke patients taking warfarin with INR 1.9?: A case report
por: Li, Zhaokun, et al.
Publicado: (2020)

Atomkärnans inre omprövas
por: Kullander, Sven
Publicado: (1986)

A team-based approach to warfarin management in long term care: A feasibility study of the MEDeINR electronic decision support system
por: Papaioannou, Alexandra, et al.
Publicado: (2010)

Pharmacy Technician Management of Stable, In-Range INRs Within a Clinical Pharmacy Anticoagulation Service
por: Hawkins, Kelsey L., et al.
Publicado: (2018)

Security and cost comparison of INR self-testing and conventional hospital INR testing in patients with mechanical heart valve replacement
por: Chen, Qiu-lin, et al.
Publicado: (2015)

Lopinavir/ritonavir/oseltamivir/warfarin interaction: Increase in the INR and alanine aminotransferase following off label use: 10 case reports
Publicado: (2020)

The comparison of non-vitamin K antagonist oral anticoagulants versus well-managed warfarin with a lower INR target of 1.5 to 2.5 in Asians patients with non-valvular atrial fibrillation
por: Chan, Yi-Hsin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k8vnefq498ioc98hd9i29d6g8n